KORU MEDICAL SYSTEMS ($NASDAQ:KRMD) declared a total revenue of USD 6.9 million for the second quarter ending June 30 2023, showing an increase of 6.0% from the same period in the prior year. Yet, their net income dropped to USD -2.5 million, a decline from the -2.9 million reported in the second quarter of 2022. The news was announced on August 9 2023.
Analyzing the financials of KORU MEDICAL SYSTEMS with GoodWhale can provide insights into its risk and performance. GoodWhale has detected 3 risk warnings in KORU MEDICAL SYSTEM’s income sheet, balance sheet, and cashflow statement. To get more detailed information, become a registered user and check out the full analysis of KORU MEDICAL SYSTEM’s financials. More…
Risk Rating Analysis
Star Chart Analysis
About the Company
Ownership (Institutional/ Fund Holdings)
Below shows the total revenue, net income and net margin for KRMD. More…
Income Statement Reports (Yearly/ Quarterly/ LTM)
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for KRMD. More…
Cash Flow Statement (Yearly/ Quarterly/ LTM)
Cash Flow Supplement
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for KRMD. More…
Balance Sheet (Yearly/ Quarterly)
Balance Sheet Supplement
||Book Value Per Share
Key Ratios Snapshot
Some of the financial key ratios for KRMD are shown below. More…
Income Statement Ratios
Balance Sheet Ratios
Cash Flow Ratios
Other Supplementary Items
|3Y Rev Growth
||3Y Operating Profit Growth
Repro-Med Systems Inc. is a leading designer and manufacturer of specialty medical devices and pharmaceuticals. Its competitors are Merit Medical Systems Inc, Touchstone International Medical Science Co Ltd, and Medeon Biodesign Inc. All three companies are large, well-established firms with strong reputations in the medical device industry.
– Merit Medical Systems Inc ($NASDAQ:MMSI)
Medsite is a medical technology company that manufactures and markets medical devices and software. The company has a market capitalization of $3.33 billion and a return on equity of 5.86%. Medsite’s products are used by healthcare professionals worldwide to improve patient care and outcomes.
– Touchstone International Medical Science Co Ltd ($SHSE:688013)
The company’s market cap is 1.86B as of 2022 and its ROE is 3.8%. The company is engaged in the medical science field and is dedicated to providing innovative products and services to improve human health.
– Medeon Biodesign Inc ($TPEX:6499)
Medeon Biodesign Inc is a medical device company that designs, manufactures, and markets products for use in the fields of cardiology, orthopedics, and general surgery. The company has a market cap of 4.43B as of 2022 and a return on equity of -6.27%. Medeon Biodesign’s products are used in the treatment of conditions such as heart disease, arthritis, and cancer. The company’s products are sold through a network of distributors and retailers worldwide.
KORU MEDICAL SYSTEMS reported total revenue of USD 6.9 million in the second quarter ending June 30 2023, indicating a 6.0% year-over-year growth. Net income decreased to USD -2.5 million, a decrease from the -2.9 million reported for the same quarter in the previous year. Investors must consider how these earnings results may impact the company’s future performance when making their decisions. The stock price should be monitored closely as market conditions continue to evolve to better understand how KORU MEDICAL SYSTEMS is affected.